منابع مشابه
Monitoring the clinician scientist scheme.
The National Clinician Scientist Scheme was devised to enable future leaders of academic medicine to continue post-doctoral research and at the same time complete their specialist registrar training. The awards are generously funded by the major grant-giving bodies and are held in a variety of specialties in academic departments across the UK. Award winners are given the suffix A to add to thei...
متن کاملCareers in academic medicine: the clinician scientist scheme.
when describing the current state of academic medicine in the UK. To take an optimistic view, the use of this term does imply recognition of a serious problem, and might stimulate attempts to solve it. A recent report from the Council of Heads of Medical Schools highlights some of the problems1. Over 10% of clinical academic posts remain unfilled despite a clear requirement for even greater num...
متن کاملRejuvenating clinician-scientist training.
Clinician-scientists are becoming increasingly rare in medicine as a whole, but especially in ophthalmology. There is a structural gap between MD-PhD training and K-series awards where interested candidates go through residency and fellowship without any structured research exposure or involvement. Furthermore, the success rate of the MD-PhD and K awards leaves much to be desired. The authors p...
متن کاملDeveloping a clinician-scientist career.
It was a pleasure and an honour to be invited to participate in this year’s CSCI symposium “Clinician Investigators: Pathway to Future Success”. Looking out into the audience, it was satisfying to see the room filled with so many trainees representing the various MD/PhD and CIP programs across Canada. As the first female graduate of University of Toronto’s MD/ PhD program, it was also very enco...
متن کاملJohn H. Laragh, MD: Clinician-Scientist
John Laragh is an outstanding clinician-scientist who discovered that renin, a mostly forgotten kidney hormone, causes essential hypertension1,2 and its complications.3 This discovery led to two new classes of drugs, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, which revolutionized the treatment of hypertension, cardiovascular disease, diabetes, and kidney disease...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Medicine
سال: 2004
ISSN: 1470-2118,1473-4893
DOI: 10.7861/clinmedicine.4-2-141